U.S. STOCKS ON THE MOVE-Walmart, JD.Com, Crinetics
U.S. STOCKS ON THE MOVE-Neogen Corp, Freight Technologies, Philip Morris
Stifel initiates Immunovant coverage with 'buy' on promising outlook
Brief: Immunovant Reports Cash Balance Of About $433 Mln As Of December 31
Immunovant Inc reports results for the quarter ended in December - Earnings Summary
Immunovant Inc expected to post a loss of 39 cents a share - Earnings Preview
Jefferies raises Roivant Sciences' PT on strong sales potential
Immunovant down on quarterly results miss
Immunovant Inc reports results for the quarter ended in September - Earnings Summary
Brief: Immunovant Reports Financial Results For The Quarter Ended Sept 30
Immunovant Inc expected to post a loss of 39 cents a share - Earnings Preview
Immunovant surges with market rebound after $75 mln stock offering
Brief: Immunovant Announces Imvt-1402, A Next Generation Anti-Fcrn
Brief: Immunovant Inc - Plan To Initiate A Phase 2 Trial In Graves' Disease In Early 2023 With Initial Results Expected In Second Half Of 2023
Immunovant Inc reports results for the quarter ended in June - Earnings Summary
Brief: Immunovant Reports Financial Results For The Quarter Ended June 30, 2022
Brief: Immunovant Reports Q4 Loss Per Common Share Of $0.41
Immunovant Inc reports results for the quarter ended in March - Earnings Summary
Immunovant Inc expected to post a loss of 38 cents a share - Earnings Preview